WILLS EYE IS HIRING – CLICK HERE TO APPLY TODAY!

Slide
WILLS EYE PRESENTATIONS BY EVENT TYPE

Wills Eye's world-renowned faculty share knowledge in 200 presentations

 

PAPERS

First NameLast NameRoleTitleTopicDayEvent Start/EndEvent TypeFormatSessionLocation
Beeran B.Meghpara, MDPanelistCataract Original PapersCataractSaturday8 AM - 9:15 AMOriginal Paper SessionIn Person, On DemandOP01S405
Zeba A.Syed, MDPanelistCornea, External Disease Original PapersCornea, External DiseaseMonday11:30 AM - 12:45 PMOriginal Paper SessionIn Person, On DemandOP12S405
Natasha Kolomeyer, MDChairGlaucoma Original PapersGlaucomaSaturday9:45 AM - 11 AMOriginal Paper SessionIn Person, On DemandOP02S405
Sunir J.Garg, MD, FACSChairRetina, Vitreous Original PapersRetinaSunday2 PM - 3:15 PMOriginal Paper SessionIn Person, On DemandOP08S405
Allen C.Ho. MDPanelistRetina, Vitreous Original Papers. "Efficacy and Safety of MCO-010 Optogenetic Therapy for Vision Restoration in Patients with Severe Vision Loss Due to RP: Two-Year TOPLINE Results from a Phas 2b/3 Randomized, Sham-Controlled Clinical Trial (RESTORE)RetinaSunday3 PM - 3:15 PMOriginal Paper SessionIn Person, On DemandOP08S405
Robert C.Sergott, MDCo-AuthorEfficacy and Safety of Lenadogene Nolparvovec Gene Therapy for LHON in Real-Life SettingsNeuro-OphthalmologySaturday2:48 PM – 2:55 PMPaperIn Person, On DemandPA023S405
Mark.Moster, MDCo-AuthorFour-Year Results of Bilateral Injection of Lenadogene Nolparvovec Gene Therapy for LHONNeuro-OphthalmologySunday2:48 PM – 2:55 PMPaperIn Person, On DemandPA047S405
Robert C.Sergott, MDCo-AuthorFour-Year Results of Bilateral Injection of Lenadogene Nolparvovec Gene Therapy for LHONNeuro-OphthalmologySunday2:48 PM – 2:55 PMPaperIn Person, On DemandPA047S405